Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Position Summary Alexion’s Strategic Decision Analysis (SDA) team’s primary purpose is to provide value added insights and analytics that shape strategic business and investment decisions made by both Alexion’s Executive Leadership Team,...
Posted: January 20, 2018, 1:20 pm
Preferred location: Any city in Florida Position Summary The Regional Sales Director, US Neurology, Southeast will be responsible for maximizing revenue by driving sales activity and providing leadership to the Neurolo...
Posted: January 20, 2018, 1:20 pm
Position Summary Alexion’s Strategic Decision Analysis team’s primary purpose is to provide insights and analytics that shape business and investment decisions made by both Alexion’s Executive Leadership Team, and Alexion’s Operating Com...
Posted: January 19, 2018, 8:00 am
Position Summary This role will be a key member of the Global Operations FP&A team. This role reports to the Director, Global Operations FP&A. The Senior Manager, will serve as a key member of the financial management team supporting th...
Posted: January 19, 2018, 8:00 am
Position Summary The Compliance and Ethics Business Partner directs Alexion’s compliance program for key US businesses. The role serves as a trusted advisor to commercial business leaders, drives the development and implementation of loc...
Posted: January 19, 2018, 8:00 am

Viewing page 1 of 34|Next Page

  Newsfeed | Subscribe  

Clark, the Director of News and Editorial Development at Brown University. Alexion Pharmaceuticals Inc. announced in September it was pulling out of Rhode Island and slashing jobs. The cuts in Rhode Island are at the Alexion plant in Smithfield — ...
Posted: January 22, 2018, 12:37 am
Alexion Pharmaceuticals (ALXN), Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) are likely to beat fourth-quarter earnings estimates, an analyst predicted, but biotech guidance will be cautious despite the windfall of tax reform. X The fo...
Posted: January 20, 2018, 2:38 am
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) have lost more than 10 percent over the past year, but one analyst is confident enough to call for upside to the stock. The Analyst Credit Suisse's Martin Auster initiated coverage of Alexion ...
Posted: January 18, 2018, 3:08 pm
Among the S&P 500’s biggest fallers on Monday January 08 was Alexion Pharmaceuticals Inc. (ALXN). The stock experienced a 2.52% decline to $119.70 with 2.86 million shares changing hands. Alexion Pharmaceuticals Inc. started at an opening price of...
Posted: January 9, 2018, 9:42 am
Jan 2 (Reuters) - Alexion Pharmaceuticals Inc said on Tuesday it had agreed to work with hedge fund Elliott Management to identify a new member to join the drugmaker’s board. Elliott, which has built a stake in Alexion, is urging the company to ta...
Posted: January 2, 2018, 5:23 pm

Viewing page 1 of 2|Next Page